Mesoblast (MEOBF) News Today $2.00 0.00 (0.00%) As of 01/29/2025 Add Compare Share Share Headlines Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Mesoblast Launches Ryoncil® in U.S. for Pediatric Graft-Versus-Host DiseaseJanuary 30 at 9:48 PM | tipranks.comMesoblast Limited Quotes New Securities on ASXJanuary 24, 2025 | tipranks.comMesoblast Boosts Capital with New Share IssuanceJanuary 24, 2025 | tipranks.comMesoblast Limited Announces Quotation of New SecuritiesJanuary 22, 2025 | tipranks.comMesoblast Limited Completes Strategic Share PlacementJanuary 22, 2025 | tipranks.comJPMorgan Chase & Co. Ceases Substantial Holding in Mesoblast LimitedJanuary 21, 2025 | tipranks.comBell Potter Remains a Buy on Mesoblast Limited (MEOBF)January 20, 2025 | markets.businessinsider.comMesoblast Director Increases Stake in CompanyJanuary 20, 2025 | tipranks.comMesoblast Limited Announces Major Share Issuance to Institutional InvestorsJanuary 19, 2025 | tipranks.comMesoblast Substantial Holding Changes Signal Institutional Strategy ShiftJanuary 16, 2025 | tipranks.comMesoblast Issues Unquoted Equity Securities for Employee IncentivesJanuary 16, 2025 | tipranks.comMesoblast Incentivizes Employees with Unquoted Equity IssuanceJanuary 15, 2025 | tipranks.comMesoblast Limited Announces Issuance of Unquoted Equity SecuritiesJanuary 15, 2025 | tipranks.comMesoblast Limited Announces Cessation of SecuritiesJanuary 15, 2025 | tipranks.comMesoblast Limited to Quote 7.2 Million New Securities on ASXJanuary 15, 2025 | tipranks.comMesoblast Secures A$260 Million for Ryoncil LaunchJanuary 13, 2025 | tipranks.comMesoblast Limited Announces Quotation of New Securities on ASXJanuary 10, 2025 | tipranks.comMesoblast Limited Initiates Trading Halt Pending Financing AnnouncementJanuary 9, 2025 | tipranks.comJPMorgan Reduces Stake in Mesoblast LimitedJanuary 9, 2025 | tipranks.comMesoblast Limited Announces Proposed Securities IssueJanuary 6, 2025 | tipranks.comMesoblast Sees Major Change in Substantial HoldingDecember 26, 2024 | tipranks.comMesoblast Director Increases Share Holdings SignificantlyDecember 23, 2024 | tipranks.comMesoblast Limited Expands Equity with New Share QuotationDecember 20, 2024 | tipranks.comMesoblast Director Increases Stake with Major Share AcquisitionDecember 20, 2024 | tipranks.comWhat's Going On With Mesoblast Shares Thursday?December 19, 2024 | benzinga.comMesoblast’s RYONCIL® is the First U.S. FDA-Approved Mesenchymal Stromal Cell (MSC) TherapyDecember 18, 2024 | markets.businessinsider.comFDA Approval Boosts Mesoblast’s Market PositionDecember 18, 2024 | tipranks.comMesoblast’s Ryoncil: A Breakthrough in Pediatric TherapyDecember 18, 2024 | tipranks.comMesoblast Limited Joins Prestigious Nasdaq Biotechnology IndexDecember 17, 2024 | tipranks.comPromising Developments and Regulatory Catalysts Highlight Mesoblast’s Growth PotentialDecember 5, 2024 | markets.businessinsider.comMesoblast’s Revascor Therapy Shows Promise in Heart FailureDecember 5, 2024 | finance.yahoo.comMesoblast’s Revascor Shows Promise in Heart Failure TreatmentDecember 2, 2024 | tipranks.comMesoblast Director Joseph Swedish Steps DownNovember 15, 2024 | markets.businessinsider.comMesoblast Issues 2 Million Warrants for Strategic FlexibilityNovember 14, 2024 | finance.yahoo.comWhen Will Mesoblast Limited (ASX:MSB) Become Profitable?October 31, 2024 | finance.yahoo.comMesoblast management to meet with MaximOctober 22, 2024 | markets.businessinsider.comMesoblast Limited (MEOBF) was upgraded to a Buy Rating at JefferiesSeptember 3, 2024 | markets.businessinsider.comMesoblast Ltd MEOBFMay 22, 2024 | morningstar.comWhy Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day SessionMarch 11, 2024 | benzinga.comJefferies Keeps Their Buy Rating on Mesoblast Limited (MEOBF)December 26, 2023 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Guangzhou Baiyunshan Pharmaceutical Holdings Company (GZPHF), Mesoblast Limited (MEOBF)December 25, 2023 | markets.businessinsider.comMesoblast Ltd ADR MESODecember 9, 2023 | morningstar.comMesoblast Limited (MEOBF) Stock Historical Prices & Data - Yahoo FinanceJanuary 11, 2023 | finance.yahoo.comMESO.O - Mesoblast limited (ADR) | Stock Price & Latest News | ReutersSeptember 29, 2022 | reuters.comMesoblast Teva StartsSeptember 29, 2022 | investing.comMesoblast Limited (MESO) Q4 2022 Earnings Call TranscriptSeptember 1, 2022 | seekingalpha.comMesoblast Limited 2022 Q4 - Results - Earnings Call PresentationSeptember 1, 2022 | seekingalpha.comMindMed Appoints Schond L. Greenway As CFOMay 25, 2022 | markets.businessinsider.comMesoblast (OTC:MEOBF), Short Interest ReportMay 25, 2022 | benzinga.comMesoblast (OTC:MEOBF), Earnings Estimates, EPS, and RevenueMay 25, 2022 | benzinga.com Get Mesoblast News Delivered to You Automatically Sign up to receive the latest news and ratings for MEOBF and its competitors with MarketBeat's FREE daily newsletter. Email Address MEOBF Media Mentions By Week MEOBF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MEOBF News Sentiment▼-0.110.72▲Average Medical News Sentiment MEOBF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MEOBF Articles This Week▼30▲MEOBF Articles Average Week Get Mesoblast News Delivered to You Automatically Sign up to receive the latest news and ratings for MEOBF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies 4Front Ventures News Algernon Pharmaceuticals News Allstar Health Brands News American Premium Mining News Anew Medical News Arno Therapeutics News AstraZeneca News AVAX Technologies News AVVAA World Health Care Products News AXIM Biotechnologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:MEOBF) was last updated on 1/31/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesoblast Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Mesoblast With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
